The phase 3 study suggests that thromboprophylaxis with the oral, once-daily direct factor Xa inhibitor is a reasonable alternative to standard anticoagulants.
IRAN: In the small randomized CANARY trial, which was reported in JAMA Cardiology, a modified reperfusion procedure for intermediate-risk pulmonary embolism (PE) appeared to be effective without.
Treatment of acute PE with the Inari thrombectomy catheter rapidly, safely boosted hemodynamics in the FLASH registry study preceding a randomized test against catheter-directed thrombolysis.
Many patients on long-term warfarin are also taking aspirin, often unnecessarily. Stopping aspirin in these patients reduces bleeding complications without any apparent harm, a new study has shown.